Equity Overview
Price & Market Data
Price: $18.78
Daily Change: +$0.37 / 1.97%
Daily Range: $18.41 - $18.95
Market Cap: $202,968,608
Daily Volume: 37,331
Performance Metrics
1 Week: 0.75%
1 Month: -9.23%
3 Months: 5.15%
6 Months: -7.62%
1 Year: 14.86%
YTD: 5.51%
Company Details
Employees: 111
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.